InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: gpb post# 3016

Tuesday, 12/24/2013 10:25:47 AM

Tuesday, December 24, 2013 10:25:47 AM

Post# of 703827
Thanks gpb. Makes sense, but raises questions.

I just listened again to the Oppenheimer presentation by Linda again. The German hospitals have applied for "Extraordinary Reimbursement". Sounds like compensation that does not require modifying the trial model.

However, she says NWBO applied for compassionate use, but she doesn't actually say if it is for Germany, The UK, or the EU. If it's for the entire EU, and is granted, then that means big revenue for the company, but from what you are saying, Europe would no longer be contributing to patient enrollment for US FDA consideration.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News